BUKOVINIAN STATE MEDICAL UNIVERSITY, CHERNIVTSI, UKRAINE.
Wiad Lek. 2023;76(11):2455-2459. doi: 10.36740/WLek202311118.
The aim: To study the determination of Mesothelin level in women with endometriosis associated with infertility and estimate influence of probiotic on endometriosis according of Mesothelin level in complex preparation before assisted reproductive technologies.
Materials and methods: In this study, we conducted a retrospective analysis of the medical records of 40 infertile women who underwent assisted reproductive technologies while also using the probiotic "Femina Probiz." We divided the participants into two groups. The control group comprised 11 women who had tubal infertility due to a previous inflammatory condition but were otherwise found to be in good health through comprehensive clinical and laboratory assessments. These women, aged between 21 and 42 with an average age of 29.75 years, did not use the probiotic "Femina Probiz." The main group consisted of 29 women diagnosed with external genital endometriosis who were undergoing assisted reproductive technologies. Women in the main group received the probiotic "Femina Probiz" from Unic Biotech Ltd, India. They took one tablet twice a day for one month as part of their overall treatment before undergoing assisted reproductive technologies. We measured the Mesothelin levels before and after this preparation phase. This study was conducted at Bukovinian State Medical University and Centre of Reproductive Medicine. It's worth noting that the primary infertility incidence was significantly higher in the main group of patients.
Results: In the main group, we observed that the Mesothelin level was 0.73±0.01, which was significantly higher than the post-preparation level (0.59±0.01). In contrast, the control group had a Mesothelin level of 0.49±0.01. Interestingly, we noted that the Mesothelin level in patients increased approximately twofold before preparation compared to those who had undergone preparation. This suggests that the use of the probiotic led to a sharp reduction in the elevated Mesothelin levels. Consequently, the significant decrease in Mesothelin levels after using the probiotic indicates its effectiveness and potential utility in the preparation phase of assisted reproductive technologies programs.
Conclusions: The elevated Mesothelin levels indicate a strong association between the pathogenesis of endometriosis and inflammation, as well as damage to the peritoneum. The incorporation of a probiotic as part of a comprehensive preparation regimen prior to assisted reproductive technologies notably enhances the overall health of patients and leads to a reduction in Mesothelin levels. Based on our findings, we highly recommend the inclusion of this probiotic preparation in clinical practice.
研究在患有与不孕相关的子宫内膜异位症的女性中 Mesothelin 水平的确定,并根据复杂制剂中 Mesothelin 水平估计益生菌对子宫内膜异位症的影响,然后在辅助生殖技术之前使用该制剂。
本研究回顾性分析了 40 名接受辅助生殖技术的不孕女性的病历,这些女性同时使用益生菌“Femina Probiz”。我们将参与者分为两组。对照组包括 11 名因先前炎症性疾病而患有输卵管不孕但通过全面临床和实验室评估被认为健康的女性。这些年龄在 21 岁至 42 岁之间、平均年龄为 29.75 岁的女性未使用益生菌“Femina Probiz”。主要组由 29 名患有外阴子宫内膜异位症的女性组成,她们正在接受辅助生殖技术。主要组的女性接受印度 Unic Biotech Ltd 的益生菌“Femina Probiz”治疗。在接受辅助生殖技术之前,她们每天服用两次一片,持续一个月作为整体治疗的一部分。我们在准备阶段前后测量了 Mesothelin 水平。这项研究在 Bukovinian 州立医科大学和生殖医学中心进行。值得注意的是,主要组患者的原发性不孕发生率明显更高。
在主要组中,我们观察到 Mesothelin 水平为 0.73±0.01,明显高于准备后水平(0.59±0.01)。相比之下,对照组的 Mesothelin 水平为 0.49±0.01。有趣的是,我们注意到在准备前,患者的 Mesothelin 水平增加了大约两倍,而准备后的水平则降低了。这表明益生菌的使用导致 Mesothelin 水平急剧下降。因此,使用益生菌后 Mesothelin 水平的显著降低表明其在辅助生殖技术方案准备阶段的有效性和潜在效用。
Mesothelin 水平升高表明子宫内膜异位症的发病机制与炎症以及腹膜损伤之间存在强烈关联。在辅助生殖技术之前,将益生菌纳入综合准备方案中可显著改善患者的整体健康状况,并降低 Mesothelin 水平。基于我们的发现,我们强烈推荐将这种益生菌制剂纳入临床实践。